RDA COVID-19 Working Group Recommendations and Guidelines: 2nd Release Published
2nd Release Highlights:
During the week since the first release we have seen the addition of two cross-cutting COVID-19 sub-groups focusing on Legal and Ethical aspects and Software. The seven sub-groups have kept up their relentless pace and the main updates in this version, with respect to the 1st release on the 24 April 2020, include:
- Section 3 -Foundational Principles/Recommendations - modifications
- Section 4 - Clinical - updated
- Section 6 - Epidemiology - revised
- Section 8 - Omics - revised
- Section 9 - Overarching Research Software Guidelines - new sub-section 9.3 initial guidelines for policy makers included
- Section 10 - Overarching Legal and Ethical Guidelines added
Furthermore, the editorial team have incorporated some of the feedback received via the Requests for Comments (RfC) process and sent directly to Co-chairs, Sub-group moderators and the Editorial team.
The social sciences and community participation sub-groups are working on updates and additions for future releases.
You are invited to visit each of the sub-group pages (accessible from the COVID-19 Working Group landing page) to see specific ongoing activities and links to documents and resources.
Timing, Future Releases and Weekly Webinars:
In terms of timing, we foresee weekly releases (every Friday) between now and 22 May 2020. More information and insights on the plans for those releases, as well as highlights from the sub-groups are given during the weekly webinar every Tuesday at 11UTC – see Events page for details and to access previous recordings and presentations.
Request for Comments:
As always, your feedback on the content of the releases, the scope, the direction, is vital for all involved to shape and focus the document and the sections to be a useful and meaningful tool. Providing comments is easy:
- Log in to the RDA web site
- Go to the Outputs page
- Scroll to the bottom of the page
- Write your comments in the box (you may upload notes/attachments too if you wish)
- Select “Save”
Call for Expertise:
The Clinical Subgroup would greatly appreciate the help from clinical imaging data and immunological data experts. Please join the COVID-19 Clinical group at https://www.rd-alliance.org/groups/rda-covid19-clinical or contact the RDA Secretariat at enquiries[at]rd-alliance.org
My sincerest appreciation for the tireless effort, resources and expertise that all groups are doing to generate these important and required Recommendations and Guidelines. This is a clear example of community collaboration, cooperation, and co-creation on a global level.
Secretary-General Research Data Alliance